Intralesional hyaluronidase injection to relieve non‐hyaluronic acid filler‐induced vascular adverse events
International Journal of Dermatology · 2024
DOI: 10.1111/ijd.17355 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Dermatology, 2024. Verfasst von Jonathan Kadouch und 4 weiteren Autor:innen. Beteiligte Einrichtung: ReSculpt Clinic, Practice for Aesthetic Dermatology, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Cosmetic Techniques, Dermal Fillers, Durapatite, Hyaluronoglucosaminidase. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Themen: Patientensicherheit
Abstract (Originalsprache)
Background
Vascular adverse events (VAEs) occurring during injections of soft‐tissue fillers are still considered a challenging issue for both patients and practitioners. Hyaluronidase can dissolve hyaluronic acid (HA)‐based soft‐tissue fillers during a VAE. For VAEs induced by non‐HA fillers, the absence of an “antidote” is regarded as exceptionally challenging.
Methods
This multicenter study describes a case series of three VAEs induced by non‐HA fillers, for which ultrasound‐guided hyaluronidase injections were incorporated into the treatment approach.
Results
Two cases of calcium hydroxylapatite and one case of poly‐L‐lactic acid‐induced VAEs are described, all of which were resolved without necrosis or scarring using a treatment approach with ultrasound‐guided hyaluronidase injections.
Conclusions
Unlike the mechanical hypothesis, which assumes filler particles travel antegrade to block arterioles in a large skin area, we hypothesize vasoconstriction as the pivot in VAEs. Filler injection‐induced spasms could lead to long‐lasting vasoconstriction of the perforator arteries stemming from the central facial arteries. Our results underscore that perforasome vasoconstriction might be the leading cause of the ischemia and subsequent necrosis in VAEs and that relaxation of these perforasomes, rather than dissolving the filler material, resolves the clinical symptoms associated with VAEs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- ReSculpt Clinic, Practice for Aesthetic Dermatology, Amsterdam, the Netherlands.
- Department of Dermatology, Erasmus Medical Centre, Rotterdam, the Netherlands.
- Groh Kliniek, Practice for Aesthetic Medicine, Bloemendaal, the Netherlands.
- Aesthetics by Viktorya, Practice for Aesthetic Medicine, Lincolnshire, IL, USA.
ORCID-Profile: Jonathan Kadouch
Zitieren
APA
Kadouch, J., Schelke, L., Groh, O., Sokol, V., & Velthuis, P. (2024). Intralesional hyaluronidase injection to relieve non‐hyaluronic acid filler‐induced vascular adverse events. International Journal of Dermatology. https://doi.org/10.1111/ijd.17355
Vancouver
Kadouch J, Schelke L, Groh O, Sokol V, Velthuis P. Intralesional hyaluronidase injection to relieve non‐hyaluronic acid filler‐induced vascular adverse events. International Journal of Dermatology. 2024. doi:10.1111/ijd.17355
BibTeX
@article{Kadouch2024,
author = {Kadouch, Jonathan and Schelke, Leonie and Groh, Olivier and Sokol, Vicky and Velthuis, Peter},
title = {Intralesional hyaluronidase injection to relieve non‐hyaluronic acid filler‐induced vascular adverse events},
journal = {International Journal of Dermatology},
year = {2024},
doi = {10.1111/ijd.17355}
}
EUVIMED